Inventor · disambiguated record
Roger John Griffin
Also filed as: GRIFFIN ROGER · GRIFFIN ROGER J · GRIFFIN ROGER JOHN
30 granted patents·8 pending applications·430 citations·filing 1987–2024
97Inventor score
Files withKUDOS PHARM LTD8ASTEX THERAPEUTICS LTD7UNIV NEWCASTLE VENTURES LTD7CANCER REC TECH LTD4CANCER RES CAMPAIGN TECH2
Top patents by PatentIndex Score
38 records- 0197US5756510ABenzamide analogs useful as PARP (ADP-ribosyltransferase, ADPRT) DNA repair enzyme inhibitorsUNIV NEWCASTLE VENTURES LTD·Filed 1996·Granted May 26, 1998·98 cites·10 claims
- 0295US10544132B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 28, 2020·10 cites·27 claims
- 0394US6310082B1Benzimidazole compoundsUNIV NEWCASTLE VENTURES LTD·Filed 2000·Granted Oct 30, 2001·43 cites·21 claims
- 0492US10981898B2Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Apr 20, 2021·4 cites·27 claims
- 0592US10526311B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2016·Granted Jan 7, 2020·6 cites·25 claims
- 0690US7402607B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2005·Granted Jul 22, 2008·16 cites·13 claims
- 0788US10414726B2Therapeutic agentsCANCER RESEARCH TECH LTD·Filed 2017·Granted Sep 17, 2019·6 cites·19 claims
- 0888US6100283ABenzimidazole compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1998·Granted Aug 8, 2000·49 cites·9 claims
- 0987US9358222B2Therapeutic agentsCANCER REC TECH LTD·Filed 2013·Granted Jun 7, 2016·9 cites·12 claims
- 1087US6156739AQuinazolinone compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Dec 5, 2000·46 cites·19 claims
- 1186US6015827ABenzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapyUNIV NEWCASTLE VENTURES LTD·Filed 1998·Granted Jan 18, 2000·28 cites·9 claims
- 1285US11261171B1Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2019·Granted Mar 1, 2022·2 cites·24 claims
- 1385US7049313B2ATM inhibitorsKUDOS PHARM LTD·Filed 2003·Granted May 23, 2006·19 cites·9 claims
- 1483US8618158B2Therapeutic agentsGOLDING BERNARD THOMAS·Filed 2009·Granted Dec 31, 2013·10 cites·19 claims
- 1582US8258175B2Isoindolin-1-one derivativesWILLEMS HENDRIKA MARIA GERARDA·Filed 2005·Granted Sep 4, 2012·10 cites·9 claims
- 1682US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 1782US2025092027A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1880US6303618B1Cyclin dependent kinase inhibiting purine derivativesCANCER RES CAMPAIGN TECH·Filed 2000·Granted Oct 16, 2001·17 cites·15 claims
- 1977US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 2073US10344017B2Pyrrolcarboxamide derivatives for the inhibition of ERK5CANCER RESEARCH TECH LTD·Filed 2015·Granted Jul 9, 2019·2 cites·20 claims
- 2171US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 2270US12071429B2Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Granted Aug 27, 2024·0 cites·27 claims
- 2370US7429660B2ATM inhibitorsKUDOS PHARM LTD·Filed 2004·Granted Sep 30, 2008·4 cites·12 claims
- 2470US7105518B2Thiopyrane-4-ones as DNA protein kinase inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Sep 12, 2006·5 cites·8 claims
- 2567US2022106287A1Isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activityASTEX THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2663US6316455B1Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compoundUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Nov 13, 2001·14 cites·8 claims
- 2761US6677345B1Cyclin dependent kinase inhibitorsCANCER RES CAMPAIGN TECH·Filed 2000·Granted Jan 13, 2004·1 cites·28 claims
- 2858US7732483B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2008·Granted Jun 8, 2010·0 cites·11 claims
- 2958US2009043091A1Atm inhibitorsKUDOS PHARM LTD·Filed 2008·Application pending·0 cites
- 3053US4992444AAntifolate agentsSTEVENS MALCOLM F G·Filed 1987·Granted Feb 12, 1991·9 cites·15 claims
- 3152US2011130386A1Dna-pk inhibitorsFRIGERIO MARK·Filed 2009·Application pending·0 cites
- 3252US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 3351US7642254B2ATM inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Jan 5, 2010·0 cites·3 claims
- 3447US6297250B1Pyrimidopyrimidine compoundsUNIV NEWCASTLE VENTURES LTD·Filed 1999·Granted Oct 2, 2001·3 cites·18 claims
- 3547US2007049588A1Atm inhibitorKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3646US6258840B1Analogues or derivatives of quercetin (prodrugs)COBRA THERAPEUTICS LTD·Filed 1997·Granted Jul 10, 2001·8 cites·22 claims
- 3744US2009326223A1Synthesis of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic acid estersGRIFFIN ROGER JOHN·Filed 2007·Application pending·0 cites
- 3836US2004110775A1Cyclin dependent kinase inhibiting purine derivativesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Roger John Griffin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →